EP Patent

EP0274734B1 — Tablet for pharmaceutical use with release at successive times

Assigned to PHARMIDEA SRL · Expires 1991-06-19 · 35y expired

What this patent protects

A tablet for pharmaceutical use able to release active substances at successive times, comprising at least: a first layer containing a portion of the active substance with suitable excipients, a barrier layer of polymer material gellable and/or soluble in water and/or aqueous liq…

USPTO Abstract

A tablet for pharmaceutical use able to release active substances at successive times, comprising at least: a first layer containing a portion of the active substance with suitable excipients, a barrier layer of polymer material gellable and/or soluble in water and/or aqueous liquids, which is interposed between said first layer and a third layer containing the remaining portion of active substance with suitable excipients, said barrier layer and said third layer being housed in a casing consisting of polymer material impermeable and insoluble in water or soluble in an alkaline environment. The part of the active substance not inserted in the casing is immediately available for dissolving, whereas the part inserted in the casing is available only after dissolution or rupture of the barrier layer and/or after solubilization of the casing.

Drugs covered by this patent

Patent Metadata

Patent number
EP0274734B1
Jurisdiction
EP
Classification
Expires
1991-06-19
Drug substance claim
No
Drug product claim
No
Assignee
PHARMIDEA SRL
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.